Welcome to the all-new Vetlearn

  • Exciting News Coming to Vetlearn in August 2014!
    Coming soon you'll be able to access...
  • Nearly 5,000 Compendium and Veterinary
    Technician
    articles
  • Thousands of industry Conference Proceedings
  • All-new articles (CE and other topics) for the
    entire healthcare team
  • Over 500 hours of interactive CE Videos
  • An engaging new community for asking
    questions, making connections and more!

To access Vetlearn, you must first sign in or register.

registernow

  • Registration for new subscribers will open in August 2014!
  • Watch for additional exciting news coming soon!
Become a Member

Reference Desk September 2011

Pfizer recalls Dexdomitor and Antisedan

    Pfizer Animal Health is voluntarily recalling one lot each from its Antisedan and Dexdomitor sterile injectable solutions.

    Dexdomitor is used as a sedative and analgesic in dogs and cats, as well as a preanesthetic to general anesthesia. Antisedan is used to reverse the sedative and analgesic effects of Dexdomitor.

    Pfizer announced Sept. 16, 2011 that the two lots may contain foreign particles originating from a glass vial manufacturing defect. The affected lots are lots 1399276 of Antisedan (expiration: March 2014) and 1391999 of Dexdomitor (expiration: January 2014).

    According to a Pfizer news release, Pfizer and manufacturing partner Orion Corporation implemented the recall after a scientific assessment that the affected lots could result in serious negative health effects.

    Customers can contact Pfizer’s Veterinary Medical Information and Product Support group with questions or for more information at 800-366-5288.

    Source: Pfizer Animal Health

    didyouknow

    Did you know... 95% of veterinarians surveyed believe that dogs and cats require at least one well-visit, or physical examination, annually and that 72% of veterinarians believe wellness exams are the most important services they can provide.Read More

    Stay on top of all our latest content — sign up for the Vetlearn newsletters.
    • More
    Subscribe